ProShare Advisors LLC Grows Position in Colgate-Palmolive Company $CL

ProShare Advisors LLC lifted its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 4.9% in the fourth quarter, HoldingsChannel.com reports. The firm owned 2,148,142 shares of the company’s stock after acquiring an additional 100,600 shares during the quarter. ProShare Advisors LLC’s holdings in Colgate-Palmolive were worth $169,746,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of CL. Blume Capital Management Inc. lifted its stake in Colgate-Palmolive by 134.1% during the 4th quarter. Blume Capital Management Inc. now owns 35,580 shares of the company’s stock worth $2,812,000 after acquiring an additional 20,380 shares in the last quarter. Integrated Investment Consultants LLC lifted its stake in Colgate-Palmolive by 264.1% during the 4th quarter. Integrated Investment Consultants LLC now owns 14,890 shares of the company’s stock worth $1,177,000 after acquiring an additional 10,800 shares in the last quarter. RiverFront Investment Group LLC lifted its stake in Colgate-Palmolive by 53.3% during the 4th quarter. RiverFront Investment Group LLC now owns 7,075 shares of the company’s stock worth $559,000 after acquiring an additional 2,459 shares in the last quarter. North Dakota State Investment Board acquired a new position in Colgate-Palmolive during the 4th quarter worth about $2,544,000. Finally, Elyxium Wealth LLC acquired a new position in Colgate-Palmolive during the 4th quarter worth about $68,000. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Colgate-Palmolive Trading Up 2.0%

CL opened at $89.89 on Tuesday. Colgate-Palmolive Company has a one year low of $74.54 and a one year high of $99.33. The company has a market cap of $72.12 billion, a P/E ratio of 34.98, a PEG ratio of 4.58 and a beta of 0.31. The company has a debt-to-equity ratio of 16.33, a quick ratio of 0.67 and a current ratio of 1.02. The business’s 50-day simple moving average is $86.24 and its 200-day simple moving average is $84.82.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, May 1st. The company reported $0.97 EPS for the quarter, beating analysts’ consensus estimates of $0.94 by $0.03. The business had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.22 billion. Colgate-Palmolive had a return on equity of 386.76% and a net margin of 10.04%.The business’s revenue for the quarter was up 8.4% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.91 EPS. As a group, equities research analysts expect that Colgate-Palmolive Company will post 3.82 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, May 15th. Shareholders of record on Monday, April 20th were given a dividend of $0.53 per share. This represents a $2.12 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date of this dividend was Monday, April 20th. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.52. Colgate-Palmolive’s payout ratio is 82.49%.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on CL shares. UBS Group increased their target price on Colgate-Palmolive from $98.00 to $100.00 and gave the stock a “buy” rating in a research note on Monday, May 4th. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $99.00 price target on shares of Colgate-Palmolive in a report on Monday, May 4th. The Goldman Sachs Group restated a “buy” rating on shares of Colgate-Palmolive in a report on Friday, May 1st. Rothschild & Co Redburn set a $100.00 price target on Colgate-Palmolive and gave the stock a “buy” rating in a report on Tuesday, April 21st. Finally, Barclays upped their price target on Colgate-Palmolive from $79.00 to $80.00 and gave the stock an “equal weight” rating in a report on Tuesday, May 5th. Twelve equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Colgate-Palmolive has an average rating of “Moderate Buy” and an average target price of $95.88.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.